Press Release | Sat Jun 8, 2013 5:50am EDT

Boehringer Ingelheim’s investigational faldaprevir+ achieved viral cure in 88% of treatment-naïve hepatitis C patients in Asia

* Reuters is not responsible for the content in this press release.